A study in healthy men to test how well different doses of BI 3802876 are tolerated

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-504538-23-00

Acronym

1517-0001

Enrollment

Registered

2023-09-25

Start date

2023-10-24

Completion date

2025-03-20

Last updated

2025-03-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteer trial

None listed

Sex/Gender

Male

Age

18 Years to 64 Years

Belgium

None listed

Source: EU CTIS · Data processed: Feb 4, 2026